Systems biology-augmented, stem cell-derived, multi-tissue panel for rapid screening of approved drugs as potential COVID-19 treatments

  • Vasan, Seshadri (Primary Chief Investigator (PCI))
  • Godde, Nathan (Chief Investigator (CI))
  • O'Brien, Carmel M. (Chief Investigator (CI))
  • Balasubramanian, Nagendrakumar Singanallur (Chief Investigator (CI))
  • Beale, David (Chief Investigator (CI))
  • Athan, Eugene (Chief Investigator (CI))
  • Blasdell, Kim (Chief Investigator (CI))
  • Chandra, Rohitash (Chief Investigator (CI))
  • Wilson, Laurence (Chief Investigator (CI))
  • Kumar, Anu (Chief Investigator (CI))
  • Creek, Darren (Associate Investigator (AI))
  • Trevaskis, Natalie (Associate Investigator (AI))
  • Kirkpatrick, Carl (Partner Investigator (PI))

Project: Research

Project Details

StatusFinished
Effective start/end date8/01/21 → 8/01/22

Keywords

  • drug repurposing
  • COVID19
  • stem cells
  • virus
  • pharmacokinetics
  • transcriptomics
  • proteomics
  • lipidomics
  • antiviral
  • organoid